Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Supernus Pharmaceuticals (SUPN) Preferred Shares: 2011-2012

Supernus Pharmaceuticals' Preferred Shares was N/A to $49,000 in Q1 2012 from the same period last year, while for Mar 2012 it was $49,000, marking a year-over-year change of. This contributed to the annual value of $49,000 for FY2011, which is N/A change from last year.
According to the latest figures from Q1 2012, Supernus Pharmaceuticals' Preferred Shares is $49,000, which was down 0.00% from $49,000 recorded in Q4 2011.
Supernus Pharmaceuticals' Preferred Shares' 5-year high stood at $49,000 during Q4 2011, with a 5-year trough of $49,000 in Q4 2011.
In the last 2 years, Supernus Pharmaceuticals' Preferred Shares had a median value of $49,000 in 2012 and averaged $49,000.